A FAVOURABLE EFFECT OF RECOMBINANT HUMAN ERYTHROPOIETIN IN THREE CASES OF LEUKAEMIC TRANSFORMATION FROM CHRONIC MYELOMONOCYTIC LEUKAEMIA